Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24223 studies found for:    WAS
Show Display Options
Rank Status Study
1 Active, not recruiting Gene Therapy for Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34 positive cells transduced with WAS encoding lentiviral vector.
2 Recruiting Gene Therapy for WAS Follow-up
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34+ cells transduced with WASP lentiviral vector
3 Completed Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
Conditions: Wiskott-Aldrich Syndrome (WAS);   X-linked Thrombocytopenia
Intervention: Drug: Interleukin-2
4 Recruiting Gene Therapy for WAS
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene
5 Recruiting Gene Therapy for Wiskott-Aldrich Syndrome (WAS)
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene
6 Completed Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)
Condition: Wiskott-Aldrich Syndrome
Intervention: Drug: Fludarabine, Busulfan, Thymoglobulin
7 Unknown  Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Conditions: Wiskott-Aldrich Syndrome;   Thrombocytopenia;   Bleeding
Interventions: Drug: Promacta (eltrombopag);   Drug: Eltrombopag/promacta
8 Unknown  Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention
Conditions: Obesity;   Cardiac Function;   Quality of Life
Interventions: Procedure: gastric bypass;   Behavioral: intensive life style intervention
9 Recruiting Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Condition: Wiskott-Aldrich Syndrome
Intervention:
10 Completed Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Interventions: Procedure: Hematopoietic stem cell transplantation;   Device: Miltenyi CliniMACS selection system;   Drug: Fludarabine, Melphalan, Thiotepa
11 Recruiting Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Intervention: Biological: Retrovirus-mediated gene transfer
12 Completed Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
Condition: HIV Infections
Interventions: Drug: Patients elected to take licensed drugs. The vaccine was not provided for evaluation;   Drug: multiple licensed drugs not randomized;   Drug: multiple licensed antiretroviral drugs; not randomized;   Other: Intended vaccine not provided, Licensed drugs provided, but were not investigated
13 Completed Study of Sequentially Applied Repetitive Transcranial Magnetic Stimulation in Obsessive- Compulsive Disorders
Condition: Obsessive-Compulsive Disorder
Intervention: Device: repetitive transcranial magnetic stimulation (Magstim rapid magnetic stimulator)
14 Completed Clipless Laparoscopic Cholecystectomy Using Harmonic Scalpel in Cirrhotic Patients a Prospective Randomized Study
Condition: Gall Bladder Stone in Cirrhotics
Interventions: Procedure: LC was done using traditional method;   Procedure: LC was done using harmonic ACE
15 Completed Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy
Conditions: Prostate Cancer;   Cardiovascular Death
Intervention: Other: No intervention was required
16 Completed the Effect of Simple Clinical Maneuver on Shoulder and Abdominal Pain a Laparascopic Gynecological Surgery:a Prospective Randomised Trial
Condition: Effect of CO2 Was Removed by Means Trandelenburg Position at Laparascopic Surgery
Intervention: Behavioral: CO2 was removed by means of trandelenburg positions
17 Suspended Make a Journal Feel as if it Was Mailed Back From the Future
Condition: Knowledge Bases
Interventions: Behavioral: Article email links;   Behavioral: Blog email links
18 Completed A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
Condition: Kidney Transplant
Interventions: Drug: Advagraf;   Drug: Corticosteroid
19 Not yet recruiting Association Study to Evaluate TFPI Gene in CAD in Han Chinese
Condition: Coronary Heart Disease
Intervention: Other: Venous blood was collected
20 Completed Clinical Evaluation of Nanoionomer Filling in Primary Teeth
Condition: Dental Caries
Interventions: Procedure: Dental caries was removed from primary molars and was filled with the recent filling material; Ketac Nano.;   Procedure: Dental caries was removed from primary molars and was filled with the conventional filling material;Vitremer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.